SEC Form 4 · accession 0000950138-19-000060
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark J Casey
Officer — General Counsel
Period of report
Feb 1, 2019
Accepted (ET)
Feb 5, 2019 · 7:59 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Feb 1, 2019 | F | 1,248 | $22.34 | D | 37,165 | D |
Table II — derivative securities
No Table II lines on this filing.